Atossa Therapeutics, Inc. Gains 19.19%
Tue, Jun 22, 2021 at 05:30 PM
Atossa Therapeutics, Inc. (ATOS:NASDAQ) rocketted at $7.02, a gain of 19.2%. The stock appeared on our News Catalysts scanner on Fri, Jun 11, 2021 at 10:18 AM in the 'BIOTECH' category. From Mon, Jun 07, 2021, the stock recorded 70.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Jun 08, 2021 at $6.82 with a volume of 43M+.
About Atossa Therapeutics, Inc. (ATOS:NASDAQ)
Atossa Genetics Inc is a clinical-stage pharmaceutical company engaged in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Top 10 Gainers:
- ALF (ALF:NASDAQ), 108.85%
- County Bancorp, Inc. (ICBK:NASDAQ), 47.29%
- Idera Pharmaceuticals, Inc. (IDRA:NASDAQ), 41.07%
- 3D Systems Corporation (DDD:NYSE), 27.67%
- SilverSun Technologies, Inc. (SSNT:NASDAQ), 24.26%
- Globalstar, Inc. (GSAT:NYSEMKT), 23.18%
- GROY (GROY:NYSEMKT), 22.35%
- Beyond Air, Inc. (XAIR:NASDAQ), 20.98%
- SharpSpring, Inc. (SHSP:NASDAQ), 19.84%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 19.19%